85 related articles for article (PubMed ID: 20565469)
21. Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels.
Fournier LS; Vanel D; Athanasiou A; Gatzemeier W; Masuykov IV; Padhani AR; Dromain C; Galetti K; Sigal R; Costa A; Balleyguier C
Eur J Radiol; 2009 Jan; 69(1):43-9. PubMed ID: 18829193
[TBL] [Abstract][Full Text] [Related]
22. MR imaging-detected breast lesions: histopathologic correlation of lesion characteristics and signal intensity data.
Siegmann KC; Müller-Schimpfle M; Schick F; Remy CT; Fersis N; Ruck P; Gorriz C; Claussen CD
AJR Am J Roentgenol; 2002 Jun; 178(6):1403-9. PubMed ID: 12034606
[TBL] [Abstract][Full Text] [Related]
23. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
[TBL] [Abstract][Full Text] [Related]
24. Follow-up frequency and compliance in women with probably benign findings on breast magnetic resonance imaging.
Marshall AL; Domchek SM; Weinstein SP
Acad Radiol; 2012 Apr; 19(4):406-11. PubMed ID: 22227041
[TBL] [Abstract][Full Text] [Related]
25. Rate of malignancy in MRI-detected probably benign (BI-RADS 3) lesions.
Spick C; Szolar DH; Baltzer PA; Tillich M; Reittner P; Preidler KW; Pinker-Domenig K; Helbich TH
AJR Am J Roentgenol; 2014 Mar; 202(3):684-9. PubMed ID: 24555608
[TBL] [Abstract][Full Text] [Related]
26. Frequency of Malignancy and Imaging Characteristics of Probably Benign Lesions Seen at Breast MRI.
Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
AJR Am J Roentgenol; 2015 Aug; 205(2):442-7. PubMed ID: 26204298
[TBL] [Abstract][Full Text] [Related]
27. BI-RADS® 3 lesions at contrast-enhanced breast MRI: is an initial short-interval follow-up necessary?
Bahrs SD; Baur A; Hattermann V; Hahn M; Vogel U; Claussen CD; Siegmann-Luz KC
Acta Radiol; 2014 Apr; 55(3):260-5. PubMed ID: 23969262
[TBL] [Abstract][Full Text] [Related]
28. Categorization of non-mass-like breast lesions detected by MRI.
Sakamoto N; Tozaki M; Higa K; Tsunoda Y; Ogawa T; Abe S; Ozaki S; Sakamoto M; Tsuruhara T; Kawano N; Suzuki T; Yamashiro N; Fukuma E
Breast Cancer; 2008; 15(3):241-6. PubMed ID: 18224381
[TBL] [Abstract][Full Text] [Related]
29. [Papillary lesions of the breast: diagnostic imaging and contribution of percutaneous needle biopsy with 14G needle].
Bazzocchi M; Berra I; Francescutti GE; Del Frate C; Zuiani C; Puglisi F; Di Loreto C
Radiol Med; 2001 Jun; 101(6):424-31. PubMed ID: 11479438
[TBL] [Abstract][Full Text] [Related]
30. Impact of breast MR in non-screening Australian clinical practice: audit data from a single-reader single-centre site.
El-Barhoun EN; Pitman AG
J Med Imaging Radiat Oncol; 2011 Oct; 55(5):461-73. PubMed ID: 22008164
[TBL] [Abstract][Full Text] [Related]
31. Benign (BI-RADS 2) lesions in breast MRI.
Spick C; Szolar DH; Tillich M; Reittner P; Preidler KW; Baltzer PA
Clin Radiol; 2015 Apr; 70(4):395-9. PubMed ID: 25649442
[TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance imaging of radial sclerosing lesions (radial scars) of the breast.
Linda A; Zuiani C; Londero V; Cedolini C; Girometti R; Bazzocchi M
Eur J Radiol; 2012 Nov; 81(11):3201-7. PubMed ID: 22386132
[TBL] [Abstract][Full Text] [Related]
33. Follow-up results of BI-RADS 3 lesions on magnetic resonance imaging: a retrospective study.
Aslan Ö; Oktay A; Eroğlu F
Diagn Interv Radiol; 2024 May; 30(3):175-182. PubMed ID: 38293846
[TBL] [Abstract][Full Text] [Related]
34. Probably benign breast MRI lesions: frequency, lesion type, and rate of malignancy.
Lourenco AP; Chung MT; Mainiero MB
J Magn Reson Imaging; 2014 Apr; 39(4):789-94. PubMed ID: 24108546
[TBL] [Abstract][Full Text] [Related]
35. Frequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging: findings from ACRIN 6667.
Weinstein SP; Hanna LG; Gatsonis C; Schnall MD; Rosen MA; Lehman CD
Radiology; 2010 Jun; 255(3):731-7. PubMed ID: 20501712
[TBL] [Abstract][Full Text] [Related]
36. [Ultrasound follow-up of palpable solid, probably benign breast lesions (BI-RADS category III)].
Graf O; Helbich TH; Fuchsjäger MH; Hopf G; Morgun M; Graf C; Mallek R
Rofo; 2004 Sep; 176(9):1251-6. PubMed ID: 15346259
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of quantitative parametric analysis for characterization of breast lesions in contrast-enhanced MR mammography.
Hauth EA; Jaeger H; Maderwald S; Stockamp C; Mühler A; Kimmig R; Forsting M
Eur Radiol; 2006 Dec; 16(12):2834-41. PubMed ID: 16896702
[TBL] [Abstract][Full Text] [Related]
38. [Quantitative parametric analysis of contrast-enhanced lesions in dynamic MR mammography].
Hauth EA; Jaeger H; Maderwald S; Mühler A; Kimmig R; Forsting M
Radiologe; 2008 Jun; 48(6):593-600. PubMed ID: 18004537
[TBL] [Abstract][Full Text] [Related]
39. BI-RADS 3 for magnetic resonance imaging.
Comstock C; Sung JS
Magn Reson Imaging Clin N Am; 2013 Aug; 21(3):561-70. PubMed ID: 23928245
[TBL] [Abstract][Full Text] [Related]
40. Management for BI-RADS category 3 lesions detected in preoperative breast MR imaging of breast cancer patients.
Gweon HM; Cho N; Kim SY; Koo HR; Seo M; Chu A; Son EJ
Eur Radiol; 2017 Aug; 27(8):3211-3216. PubMed ID: 28083693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
